Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

Trial Profile

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Letrozole (Primary) ; Anastrozole
  • Indications Early breast cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms FACE
  • Sponsors Novartis
  • Most Recent Events

    • 23 Jan 2017 Final results published in the Journal of Clinical Oncology.
    • 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
    • 12 Dec 2015 Primary endpoint "Disease-free survival rate" has not been met, as per the results presented at the 38th Annual San Antonio Breast Cancer Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top